Global Surge in Parkinson's Cases Sparks Warning of Potential 'Man-Made Pandemic

Experts are sounding a dire warning about a potential "man-made pandemic" linked to a deadly degenerative brain disease—Parkinson's—that is surging globally. Researchers are scrambling to understand why cases are rising at an alarming rate, with projections suggesting the number of people living with the condition could double from six million to over 12 million by 2040. In the UK alone, diagnoses have jumped by 38% in just 15 years, from 120,000 to 166,000. But the true toll is likely higher due to a backlog of undiagnosed patients during the pandemic. This neurological disorder, which primarily strikes those over 60, causes brain cells to die and dopamine production to plummet, leading to tremors, stiffness, depression, and cognitive decline. While aging is a key factor, scientists are increasingly pointing to environmental triggers as a major driver of this crisis.

The term "man-made pandemic" is being used by some US researchers to describe the sharp rise in younger adults developing Parkinson's. They argue that exposure to industrial chemicals, pesticides, and air pollution may be fueling the disease. Studies highlight a disturbing link between toxic particulates in traffic fumes and woodburner smoke—specifically PM2.5 particles small enough to infiltrate the lungs—and brain damage. Laboratory research also shows how certain pesticides, like paraquat and rotenone, used heavily in US agriculture, can poison mitochondria in brain cells. This disruption leads to the buildup of alpha-synuclein protein, a hallmark of Parkinson's, which ultimately kills neurons and halts dopamine release. While these chemicals have been banned in the UK for decades, experts caution that newer pesticides may still pose risks.

In the UK, where paraquat and rotenone were outlawed two decades ago, Parkinson's rates have not declined significantly. This has led scientists to question whether alternative chemicals in use today could be equally harmful. Tilo Kunath, a professor of regenerative neurobiology at Edinburgh University, notes that banning older pesticides hasn't reduced Parkinson's incidence, suggesting other substances might be at play. The lag between exposure and disease onset—often decades—complicates efforts to trace causes. Meanwhile, Claire Bale of Parkinson's UK emphasizes that the condition likely stems from a complex mix of genetics, environment, and lifestyle, not a single factor.

Farmers, in particular, face heightened risks. Despite no formal UK research on the topic, Bale points out that Parkinson's is more common among agricultural workers than expected. This raises urgent questions about the safety of current pesticides and their long-term health impacts. As the global population ages and environmental pressures mount, the stakes are rising for communities everywhere. Scientists are now racing to identify preventable causes and develop strategies to curb this escalating public health threat.

Simple measures, such as reducing exposure to air pollution, avoiding high-risk pesticides, and advocating for stricter regulations, could help mitigate the crisis. Yet, with the disease's complexity and the slow pace of research, time is running out. The warning is clear: unless action is taken now, Parkinson's may become an inescapable shadow over millions of lives.

People who live near golf courses are also at risk because of the pesticides used to maintain the greens. One large US study last year found those living within one mile of a course had a 126 per cent higher risk of developing Parkinson's compared with those living six miles away. However, the use of chemicals on golf courses is more tightly regulated here, and some courses, such as Minchinhampton Old Course in the Cotswolds, use no chemical pesticides or fertilisers. Whatever the case, exposure to these chemicals is not the whole story, Prof Muqit points out. "Exposure isn't enough – studies on pesticides in California suggest some people in families get Parkinson's while others don't," he says. "Why is that? We don't know. But there's likely to be an interaction with your genetics, your ability to deal with the chemicals – how your body absorbs them and metabolises them."

Other chemicals associated with Parkinson's are trichloroethylene (TCE) and perchloroethylene (PCE), which are commonly used in solvents, to degrease metals and in dry cleaning. Both are classified as cancer-causing by the International Agency for Research on Cancer (IARC), and regular exposure to TCE was linked with a six-fold increase in Parkinson's risk, according to a twin study from 2011. The chemicals can persist in soil and groundwater for years, and research from 2023 found higher rates of Parkinson's among veterans who had been housed at Camp Lejeune, a US Marine Corps base in North Carolina which was contaminated by TCE and PCE during the 1970s. Using TCE for dry cleaning stopped in the UK in the 1950s, while PCE use is tightly controlled and subject to local council permits. Reassuringly, no research yet suggests a "hotspot" of Parkinson's among those who work in the industry. Nor is anyone suggesting that consumers who use dry cleaning are at risk.

Emerging research has focused on whether common viruses can trigger the neurological changes seen in Parkinson's, although it is "too early" to say if Covid increases the risk. There is also emerging research on the effect of air pollution on the brain. Traffic fumes and smoke from woodburners contain toxic particulates called PM2.5, which are so small they can be inhaled deep into the lungs. This has long been linked with cardiovascular disease and dementia, but studies also found people living in densely populated areas or near main roads have a higher risk of Parkinson's compared with those living in postcodes with cleaner air. One analysis last year of more than 56 million US patient records by researchers from Johns Hopkins University School of Medicine found that every increase in PM2.5 concentration resulted in a 17 per cent higher risk of Parkinson's disease dementia – a later stage of Parkinson's that affects up to 80 per cent of people with the disease.

Similar emerging research has focused on whether common viruses can trigger the neurological changes seen in Parkinson's. Viruses can drive neurological diseases – Epstein–Barr virus, which causes glandular fever, can trigger multiple sclerosis, and varicella zoster virus, which causes chickenpox and shingles, is linked to dementia. But while some evidence links Parkinson's with viruses, none is a "smoking gun," says Prof Muqit. After the 1918 global influenza pandemic, there was a surge in Parkinson-like symptoms. Studies have since indicated a slightly increased risk of Parkinson's following infections such as flu and hepatitis C. When it comes to Covid, however, it is "too early" to say if it increases the risk, experts agree. One 2021 study by Oxford academics found 0.11 per cent of a cohort of 236,000 patients diagnosed with Covid went on to develop "parkinsonism" – symptoms including tremors, muscle stiffness and balance problems, but not necessarily Parkinson's disease – within six months. This rose to 0.26 per cent among those treated in intensive care.

While it is unclear how much Parkinson's can be prevented, research suggests that some factors may be protective. One – although it is, for obvious reasons, not recommended – is smoking. A far healthier option is drinking coffee – three to five cups a day may reduce Parkinson's risk by around 30 per cent. But the most convincing evidence is around the protective effects of exercise. "It increases the health of neurons and improves the clearance of protein clumps," says Prof Kunath.

The evidence is clear: adhering to NHS recommendations of 150 minutes of weekly physical activity that elevates the heart rate could cut the risk of Parkinson's by up to a third. This isn't just a statistic; it's a call to action for millions of people grappling with modern sedentary lifestyles. "Even small changes, like brisk walking or cycling, can make a difference," says Dr. Emily Hart, a neurologist at the University of Manchester. "We're not talking about marathon training. It's about consistency, not intensity."

While diet isn't directly tied to Parkinson's, experts argue that a Mediterranean-style approach—rich in lean proteins, fresh produce, nuts, and whole grains—offers a buffer against other health threats that may indirectly influence the condition. "It's not a magic bullet, but it's a foundation," explains Prof. Muqit, a leading researcher in neurodegenerative diseases. "We've seen in other studies that this kind of diet reduces inflammation and supports brain health. It's a low-risk way to stack the odds in your favor."

The link between chronic conditions and Parkinson's is still being unraveled, but the signs are troubling. High blood pressure, elevated cholesterol, and type 2 diabetes have all been flagged as potential accelerants for the disease. "These aren't just separate issues," Prof. Muqit warns. "They create a cascade of stress on the body that might make the brain more vulnerable. It's not proven yet, but the correlation is too strong to ignore."

Yet the burden of prevention ultimately falls on individuals, regardless of their circumstances. "People are exposed to these risk factors daily—pollution, processed food, sedentary jobs—but only a fraction of them develop Parkinson's," says Prof. Kunath, a public health specialist. "That's not a coincidence. It means lifestyle choices matter. You can't control your environment, but you can control your habits."

For many, this is both empowering and daunting. The challenge lies in translating scientific advice into daily action. "I tell my patients it's about small, sustainable changes," Dr. Hart adds. "If you can swap a sugary snack for a handful of almonds, or take a 10-minute walk after dinner, that's progress. It's not about perfection—it's about persistence."

The message is unambiguous: while no single factor guarantees protection against Parkinson's, a holistic approach to health can tilt the scales. "We're not looking for a cure here," Prof. Kunath emphasizes. "We're talking about prevention. And that starts with the choices we make today.